—
Animal Vaccines Market – OverviewAnimal vaccines are part of a category of animal medicines which work primarily by stimulating an animal’s immune system to prevent or treat diseases. The main aim of animal vaccines is to improve the health and welfare of companion animals, prevent animal-to-human transmission and increase production of livestock in a cost-effective manner.
On the regional basis, the American market for animal vaccines is segmented into North America and South America. The North America market is estimated to drive the market growth owing to the increasing incidence of livestock diseases, technological advancements, rising government initiatives and strong R&D investments. For instance, in 2018, Boehringer Ingelheim announced to reinforce its leading position in the veterinary vaccine market with 70 million euro investment in the R&D and biological production activities.
TRY PRIME SAMPLE REPORT @ https://www.marketresearchfuture.com/sample_request/7184
Rising pet adoption is also boosting the animal vaccines market in the US region. According to the American Society for the Prevention of Cruelty to Animals (ASPCA), nearly 6.5 million companion animals enter US animal shelters nationwide every year.
Animal Vaccines Market - Key players
Some of the key players in the global animal vaccines market are Bayer AG, Biogenesis Bago, Boehringer Ingelheim GmbH, China Animal Husbandry, Elanco Animal Health, Hester, Idt Biologika, Indian Immunologicals Limited, Merck Animal Health, MSD Animal Health, Phibro Animal Health, Tianjin Ringpu, Vetoquinol, Zoetis Inc., and others.
Animal Vaccines Market - Segmentation
The global animal vaccines market is segmented based on type, technology, indications, composition and region.
The global market for animal vaccines, by type is segmented into static porcine vaccines, poultry vaccines, livestock vaccines, companion animal vaccines, aquaculture vaccines, and others. The livestock vaccine is further segmented into bovine vaccines, and small ruminant vaccines. The livestock vaccine is further segmented into canine vaccines, and feline vaccines.
The market, by technology, is segmented into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and others.
Based on indications, the market is segmented into foot & mouth disease, parvovirus, distemper, reproductive & respiratory syndrome, and others.
Based on composition, the market is segmented into mono vaccine, and combination vaccines.
Animal Vaccines Market - Regional Analysis
The Americas dominated the global market for animal vaccines owing to the presence of major market players, rising pet adoption and developed economies like US and Canada within the region. According to the American Society for the Prevention of Cruelty to Animals (ASPCA), nearly 6.5 million companion animals enter US animal shelters nationwide every year.
In 2017, it was estimated that Europe stood second in the global animal vaccines market. This can be attributed to the rising research and development investments. For instance, in 2018, Boehringer Ingelheim announced to reinforce its leading position in the veterinary vaccine market with 70 million euro investment in the R&D and biological production activities.
BROWSE COMPLETE 90 PAGES PREMIUM RESEARCH REPORT ENABLED WITH 98 RESPECTIVE TABLES AND FIGURES @ https://www.marketresearchfuture.com/reports/animal-vaccines-market-7184
Asia Pacific was projected to be the fastest growing region in 2017. Increasing awareness about animal health drives the regional markets of the Asia Pacific region. In 2016, at the 5th Global Animal Health Conference, HealthforAnimals association called for greater cooperation between national governments to improve market access for veterinary medicines.
On the other hand, the Middle East and Africa held least share in the global animal vaccines market due to the low per capita income, especially within the African region. The market growth in this region is expected to be driven by increasing cases of zoonotic diseases. According to a 2015 study published in the PLOS journal, annual incidences of human rabies in the Middle Eastern countries vary from 0.02 to 1.3 per million human populations.
Some Points form Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
GET PREMIUM DISCOUNT @ https://www.marketresearchfuture.com/check-discount/7184
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future
Address: Contact Us:, , Market Research Future, , Office No. 528, Amanora Chambers, , Magarpatta Road, Hadapsar,, , Pune - 411028, , Maharashtra, India, , Phone: +1 646 845 9312, , Email: sales@marketresearchfuture.com,
Phone: +1 646 845 9312
Website: https://www.marketresearchfuture.com/reports/animal-vaccines-market-7184
Release ID: 473565
Google
RSS